Sandra Müller

Sandra Müller

Company: Molecular Partners AG

Job title: Scientist Oncology Research


Application of the DARPin® Technology for Specific Targeting of Peptide: MHC Complexes 1:00 pm

Discussing DARPin® proteins that represent a compelling alternative to specifically target peptide MHC complexes: They are highly potent and specific Favorable properties of the DARPin® proteins enable fast and straight forward manufacturing, facilitating the developabilityRead more

day: Day One

© Copyright 2018 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Suite A, 6 Honduras Street, London EC1Y 0TH.